ArticleCancer immunology, immunotherapy : CII2025

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Jia-Yi Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.